|
1
|
Dalton SR, Gerami P, Kolaitis NA, Charzan
S, Werling R, LeBoit PE and Bastian BC: Use Of fluorescence in-situ
hybridization (Fish) to distinguish intranodal nevus from
metastatic melanoma. Am J Surg Pathol. 34:231–237. 2010.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Dabas N, Byrnes DM, Rosa AM, Eller MS and
Grichnik JM: Diagnostic role of chromosomal instability in
melanoma. J Skin Cancer. 2012(914267)2012.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Mihulecea CR and Rotaru M: Review: The key
factors to melanomagenesis. Life (Basel). 13(181)2023.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Jitariu AA, Cimpean AM, Kundnani NR and
Raica M: Platelet-derived growth factors induced lymphangiogenesis:
Evidence, unanswered questions and upcoming challenges. Arch Med
Sci. 11:57–66. 2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Bastian BC, Olshen AB, LeBoit PE and
Pinkel D: Classifying melanocytic tumors based on DNA copy number
changes. Am J Pathol. 163:1765–1770. 2003.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Mihulecea CR, Frățilă S and Rotaru M:
Clinical-dermoscopic similarities between atypical nevi and early
stage melanoma. Exp Ther Med. 22(854)2021.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Lai Y, Wu Y, Liu R, Lu A, Zhou L, Jia L,
Diao X and Li Z: Four-color fluorescence in-situ hybridization is
useful to assist to distinguish early stage acral and cutaneous
melanomas from dysplastic junctional or compound nevus. Diagn
Pathol. 15(51)2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Vergier B, Prochazkova-Carlotti M, de la
Fouchardière A, Cerroni L, Massi D, De Giorgi V, Bailly C,
Wesselmann U, Karlseladze A, Avril MF, et al: Fluorescence in situ
hybridization, a diagnostic aid in ambiguous melanocytic tumors:
European study of 113 cases. Mod Pathol. 24:613–623.
2011.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ferrara G and De Vanna AC: Fluorescence in
situ hybridization for melanoma diagnosis: A review and a
reappraisal. Am J Dermatopathol. 38:253–269. 2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Senetta R, Paglierani M and Massi D:
Fluorescence in-situ hybridization analysis for melanoma diagnosis.
Histopathology. 60:706–714. 2012.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Keung EZ and Gershenwald JE: The eighth
edition American Joint Committee on Cancer (AJCC) melanoma staging
system: Implications for melanoma treatment and care. Expert Rev
Anticancer Ther. 18:775–784. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Mihulecea CR, Iancu GM, Leventer M and
Rotaru M: The many roles of dermoscopy in melanoma detection. Life
(Basel). 13(477)2023.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Miedema J and Andea AA: Through the
looking glass and what you find there: Making sense of comparative
genomic hybridization and fluorescence in situ hybridization for
melanoma diagnosis. Mod Pathol. 33:1318–1330. 2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Moore MW and Gasparini R: FISH as an
effective diagnostic tool for the management of challenging
melanocytic lesions. Diagn Pathol. 6(76)2011.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Deng YN, Xia Z, Zhang P, Ejaz S and Liang
S: Transcription factor RREB1: From target genes towards biological
functions. Int J Biol Sci. 16:1463–1473. 2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Newman MD, Lertsburapa T, Mirzabeigi M,
Mafee M, Guitart J and Germai P: Fluorescence in situ hybridization
as a tool for microstaging in malignant melanoma. Mod Pathol.
22:989–995. 2009.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Horst BA, Fang Y, Silvers DN and Busam KJ:
Chromosomal aberrations by 4-color fluorescence in situ
hybridization not detected in spitz nevi of older individuals. Arch
Dermatol. 148:1152–1156. 2012.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Gerami P, Mafee M, Lurtsbarapa T, Guitart
J, Haghighat Z and Newman M: Sensitivity of fluorescence in situ
hybridization for melanoma diagnosis Using RREB1, MYB, Cep6, and
11q13 probes in melanoma subtypes. Arch Dermatol. 146:273–278.
2010.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Nijhawan RI, Votava HJ and Mariwalla K:
Clinical application and limitations of the fluorescence in situ
hybridization (FISH) assay in the diagnosis and management of
melanocytic lesions: A report of 3 cases. Cutis. 90:189–195.
2012.PubMed/NCBI
|
|
20
|
Kerl K, Palmedo G, Wiesner T, Mentzel T,
Rütten A, Schärer L, Paredes B, Hantschke M and Kutzner H: A
proposal for improving multicolor FISH sensitivity in the diagnosis
of malignant melanoma using newly combined criteria. Am J
Dermatopathol. 34:580–585. 2012.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Gerami P, Jewell SS, Morrison LE, Blondin
B, Schulz J, Ruffalo T, Matushek P IV, Legator M, Jacobson K,
Dalton SR, et al: Fluorescence in situ hybridization (FISH) as an
ancillary diagnostic tool in the diagnosis of melanoma. Am J Surg
Pathol. 33:1146–1156. 2009.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Fang Y, Dusza S, Jhanwar S and Busam KJ:
Fluorescence in situ hybridization (FISH) analysis of melanocytic
nevi and melanomas: Sensitivity, specificity, and lack of
association with sentinel node status. Int J Surg Pathol.
20:434–440. 2012.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Gaiser T, Kutzner H, Palmedo G, Siegelin
MD, Wiesner T, Bruckner T, Hartschuh W, Enk AH and Becker MR:
Classifying ambiguous melanocytic lesions with FISH and correlation
with clinical long-term follow up. Mod Pathol. 23:413–419.
2010.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Tetzlaff MT, Wang WL, Milless TL, Curry
JL, Torres-Cabala CA, McLemore MS, Ivan D, Bassett RL and Prieto
VG: Ambiguous melanocytic tumors in a tertiary referral center: the
contribution of fluorescence in situ hybridization (FISH) to
conventional histopathologic and immunophenotypic analyses. Am J
Surg Pathol. 37:1783–1796. 2013.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Moral RM, Monteagudo C, Muriel J, Moreno L
and Peiró AM: Fluorescent in situ hybridization (FISH): A useful
diagnostic tool for childhood conjunctival melanoma. European J
Ophthalmol. 32:NP13–NP19. 2022.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Chrzanowska NM, Kowalewski J and
Lewandowska MA: Use of fluorescence in situ hybridization (FISH) in
diagnosis and tailored therapies in solid tumors. Molecules.
25(1864)2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Zulauf EE, Connors JC, Hardy MA, Hild G
and Coyer MA: Use of fluorescence in situ hybridization for
diagnosis of rare nevoid melanoma: A case report. Foot & Ankle
Surgery: Techniques, Reports & Cases. 1(100013)2021.
|
|
28
|
Abásolo A, Vargas MT, Ríos-Martín JJ,
Trigo I, Arjona A and González-Cámpora R: Application of
fluorescence in situ hybridization as a diagnostic tool in
melanocytic lesions, using paraffin wax-embedded tissues and
imprint-cytology specimens. Clin Exp Dermatol. 37:838–843.
2012.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Hossain D, Qian J, Adupe J, Drewnowska K
and Bostwick DG: Differentiation of melanoma and benign nevi by
fluorescence in-situ hybridization. Melanoma Res. 21:426–430.
2011.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Moy A, Duncan L and Kraft S: Lymphatic
invasion and angiotropism in primary cutaneous melanoma. Lab
Invest. 97:118–129. 2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Nardone B, Martini M, Busam K, Marghoob A,
West DP and Gerami P: Integrating clinical/dermatoscopic findings
and fluorescence in situ hybridization in diagnosing melanocytic
neoplasms with less than definitive histopathologic features. J Am
Acad Dermatol. 66:917–922. 2012.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Carbone A: Cancer classification at the
crossroads. Cancers (Basel). 12(980)2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
de Klein A, Koopmans AE and Kilic E:
Multicolor FISH with improved sensitivity and specificity in the
diagnosis of malignant melanoma. Expert Rev Mol Diagn. 12:683–685.
2012.PubMed/NCBI View Article : Google Scholar
|
